Heng Yang

8PUBLICATIONS
30CO-AUTHORS
Solid tumoursMolecular targetsInnate immunityInfectious diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 13, 2026
Dual Inhibition of LAG-3 and PD-1 with IBI110 and Sintilimab in Advanced Alveolar Soft Part Sarcoma: A Single-Center, Phase II Trial.

|Oct 15, 2025
EP300 compromises antitumor immunity by increasing SOCS1 expression.

Yanqiong Zeng, Ying Zhou, Jiayin Ruan

|Jan 09, 2024
The aldehyde dehydrogenase ALDH1B1 exerts antiviral effects through the aggregation of the adaptor MAVS.

Nina Sun, Qiaomei Cai, Yurui Zhang

|Oct 13, 2023
DNA damage induced by CDK4 and CDK6 blockade triggers anti-tumor immune responses through cGAS-STING pathway.

Huimin Fan, Wancheng Liu, Yanqiong Zeng

|Mar 10, 2023
HDAC3 Inhibition Promotes Antitumor Immunity by Enhancing CXCL10-Mediated Chemotaxis and Recruiting of Immune Cells.

Lili Li, Shumin Hao, Meiling Gao

|Sep 13, 2021
Methods to Identify Immunogenic Peptides in SARS-CoV-2 Spike and Protective Monoclonal Antibodies in COVID-19 Patients.

Lili Li, Meiling Gao, Jie Li

Pageof 2

Frequent Collaborators

5 joint publications

Genhong Cheng

1 joint publications

Yong-Qiang Deng

1 joint publications

Lili Li

1 joint publications

Shumin Hao